切换至 "中华医学电子期刊资源库"
高级检索
中华乳腺病杂志(电子版)

中华乳腺病杂志(电子版) ›› 2020, Vol. 14 ›› Issue (03) : 134 -140. doi: 10.3877/cma.j.issn.1674-0807.2020.03.002

所属专题： 文献；

论著

免除乳房假体区域放射治疗对乳腺癌术后一期假体重建并发症及复发、转移的影响
李兴刚1, 张晔2, 冉凤伟2, 杜俊泽2, 钟玲2, 崔翔2, 张毅2, 姜军2, 范林军2,†()   
  1. 1. 644000　四川省宜宾市第三人民医院肝胆胰乳甲外科
    2. 400038　重庆，陆军军医大学第一附属医院乳腺甲状腺外科
  • 收稿日期:2020-02-20 出版日期:2020-06-01
  • 通信作者: 范林军

Effect of exempting radiotherapy in implant area on complications, recurrence and metastasis of breast cancer patients undergoing primary breast reconstruction

Xinggang Li1, Ye Zhang2, Fengwei Ran2, Junze Du2, Ling Zhong2, Xiang Cui2, Yi Zhang2, Jun Jiang2, Linjun Fan2,†()   

  1. 1. Department of Hepatopancreatobiliary, Breast and Thyroid Surgery, Third People’s Hospital of Yibin, Yibin 644000, Sichuan Province, China
    2. Department of Breast and Thyroid Surgery, First Affiliated Hospital of Army Medical University, Chongqing 400038, China
  • Received:2020-02-20 Published:2020-06-01
  • Corresponding author: Linjun Fan
  • About author:
    Corresponding author: Fan Linjun, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

李兴刚, 张晔, 冉凤伟, 杜俊泽, 钟玲, 崔翔, 张毅, 姜军, 范林军. 免除乳房假体区域放射治疗对乳腺癌术后一期假体重建并发症及复发、转移的影响[J/OL]. 中华乳腺病杂志(电子版), 2020, 14(03): 134-140.

Xinggang Li, Ye Zhang, Fengwei Ran, Junze Du, Ling Zhong, Xiang Cui, Yi Zhang, Jun Jiang, Linjun Fan. Effect of exempting radiotherapy in implant area on complications, recurrence and metastasis of breast cancer patients undergoing primary breast reconstruction[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2020, 14(03): 134-140.

目的

探讨乳腺癌术后一期假体重建患者免除乳房假体区域放射治疗对并发症及复发、转移的影响。

方法

依据纳入、排除标准，选取2012年1月至2014年12月在陆军军医大学第一附属医院乳腺甲状腺外科确诊为乳腺癌，且行根治性切除加假体植入一期乳房重建术后放射治疗的95例患者进行回顾性研究。所有患者中，接受乳房假体区域加淋巴结引流区域放射治疗者56例(对照组)，免除乳房假体区域放射治疗而仅接受淋巴结引流区域放射治疗者39例(试验组)。每例患者经过5年以上的随访。对比分析2组患者放射治疗相关并发症(放射性皮肤损伤、放射性肺炎、包膜挛缩和假体取出)，以及肿瘤局部复发和远处转移的情况。放射治疗相关并发症发生率、肿瘤局部复发率及远处转移率的比较，采用χ2检验或Fisher确切概率检验。

结果

对照组56例患者中，发生5例(8.9%)放射性皮肤损伤，2例(3.6%)放射性肺炎，5例(8.9%)放射治疗引起的包膜挛缩(Ⅱ级和Ⅲ级各2例，Ⅳ级1例)，共导致2例(3.6%)假体取出，而试验组39例患者中，只发生1例(2.6%)放射性皮肤损伤；2组相比，放射性皮肤损伤、放射性肺炎、放射治疗引起的包膜挛缩和假体取出发生率的差异均无统计学意义(P＝0.395、0.511、0.076、0.511)。对照组共有12例(21.4%，12/56)患者发生放射治疗相关并发症，试验组仅1例(2.6%，1/39)患者发生放射治疗相关并发症，2组相比，差异有统计学意义(χ2＝6.926，P＝0.008)。中位随访66个月(范围：60～81个月)，对照组发生局部复发4例(7.1%，4/56)和远处转移5例(8.9%，5/56)，试验组局部复发和远处转移均为3例(7.7%，3/39)，2组比较，差异均无统计学意义(P＝0.999、0.999)。

结论

对于接受乳腺癌根治性切除术后一期假体重建的患者，免除乳腺假体区域放射治疗不影响其疗效，同时可以减少放射治疗相关并发症，改善患者术后生活质量。

关键词: 乳腺肿瘤, 放射肿瘤学, 手术后并发症, 肿瘤复发，局部, 肿瘤转移, 无病生存
Objective

To explore the effect of exempting radiotherapy in implant area on the complications, recurrence and metastasis of patients undergoing primary breast reconstruction after breast cancer surgery.

Methods

A total of 95 patients with breast cancer who underwent radiotherapy after mastectomy and immediate implant breast reconstruction in the Department of Breast and Thyroid Surgery, First Affiliated Hospital of Army Medical University from January 2012 to December 2014 were enrolled into a retrospective study according to the inclusion and exclusion criteria. Fifty-six patients received radiotherapy in implant area and lymph node drainage area (control group) and 39 patients received radiotherapy only in lymph node drainage area (experimental group). All patients were followed up for over five years. The radiotherapy-related complications (radiation skin injury, radiation pneumonitis, capsule contracture and implant removal), local recurrence and distant metastasis of breast cancer were compared between two groups. The incidences of radiotherapy-related complications, local recurrence and distant metastasis were compared using the χ2 test or Fisher’s exact test between two groups.

Results

In the 56 patients of the control group, 5 cases(8.9%) had radiation skin injury, 2 (3.6%) radiation pneumonia, and 5 (8.9%) capsular contracture caused by radiotherapy (2 in grade Ⅱ, 2 in grade Ⅲ and 1 in grade Ⅳ), resulting implant removal in 2 cases(3.6%). Only one case (2.6%) had radiation skin injury in the experimental group. There were no significant differences in the incidences of radiation skin damage (P=0.395), radiation pneumonia (P=0.511), radiation-induced capsular contractures (P=0.076) and implant removal (P=0.511) between two groups. Twelve patients (21.4%, 12/56)in the control group and only one patient(2.6%, 1/39) in the experimental group had radiotherapy-related complications, indicating a significant difference between two groups (χ2=6.926, P=0.008). All patients were followed up for 60-81 months (median 66 months). Four cases (7.1%, 4/56) had local recurrence and 5 cases (8.9%, 5/56) had distant metastasis in the control group. Three cases(7.7%, 3/39) had local recurrence and 3 cases(7.7%, 3/39) had distant metastasis in the experimental group. There was no significant difference in the incidences of local recurrence (P=0.999) and distant metastasis (P=0.999) between two groups.

Conclusion

For patients undergoing primary implant breast reconstruction after mastectomy, exempting radiotherapy in implant area can reduce the incidence of radiation-related complications and improve the quality of life after surgery, without affecting efficacy.

Key words: Breast neoplasms, Radiation oncology, Postoperative complications, Neoplasm recurrence, local, Neoplasm metastasis, Disease-free survival
图1 乳腺癌腔镜手术切口示意图
图2 乳腺癌患者术后放射治疗靶区示意图　a～d图中蓝线范围分别代表胸壁野(乳房假体区域)、胸壁野＋内乳野、锁骨上野和腋窝照射野
表1 对照组与试验组乳腺癌患者临床资料比较
组别 例数 年龄(岁，±s) TNM分期(例) 腋窝淋巴结转移数目[枚，M(P25～P75)] ER(例) PR(例) HER-2(例)
Ⅱ期 Ⅲ期 阳性 阴性 阳性 阴性 阳性 阴性
对照组 56 38.9±7.4 33 23 2(2～4) 39 17 35 21 11 45
试验组 39 39.4±7.0 26 13 2(2～4) 32 7 29 10 8 31
检验值 ? t＝0.331 χ2＝0.585 Z＝0.085 χ2＝1.875 χ2＝1.471 χ2＝0.011
P值 ? 0.741 0.444 0.932 0.171 0.225 0.917
表2 对照组与试验组乳腺癌患者放射治疗区域比较(例)
组别 例数 胸壁野 锁骨上/下野 腋窝 内乳野
是 否 是 否 是 否 是 否
对照组 56 56 0 48 8 32 24 15 41
试验组 39 0 39 34 5 27 12 10 29
χ2值 ? 95.000 0.042 1.427 0.016
P值 ? <0.001 0.838 0.232 0.901
表3 对照组与试验组乳腺癌患者放射治疗相关并发症发生率比较(例)
组别 例数 放射性皮肤损伤 放射性肺炎 包膜挛缩 假体取出 并发症合计
是 否 是 否 是 否 是 否
对照组 56 5 51 2 54 5 51 2 54 12
试验组 39 1 38 0 39 0 39 0 39 1
χ2值 ? ? ? ? ? ? ? ? ? 6.926a
P值 ? 0.395 0.511 0.076 0.511 0.008
[1]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[2]
Salhab M, Al Sarakbi W, Joseph A, et al. Skin-sparing mastectomy and immediate breast reconstruction: patient satisfaction and clinical outcome[J]. Int J Clin Oncol，2006, 11(1): 51-54.
[3]
DellaCroce FJ, Wolfe ET. Breast reconstruction[J]. Surg Clin North Am，2013, 93(2): 445-454.
[4]
Sbitany H. Breast reconstruction[J]. Surg Clin North Am，2018, 98(4): 845-857.
[5]
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials [J]. Lancet，2005, 366(9503): 2087-2106.
[6]
Rozen WM, Ashton MW, Taylor GI. Defining the role for autologous breast reconstruction after mastectomy: social and oncologic implications[J]. Clin Breast Cancer，2008, 8(2): 134-142.
[7]
Hunsicker LM, Ashikari AY, Berry C, et al. Short-term complications associated with acellular dermal matrix-assisted direct-to-implant breast reconstruction[J]. Ann Plast Surg，2017, 78(1): 35-40.
[8]
范林军，姜军，杨新华，等. 全腔镜乳腺癌皮下腺体切除一期假体植入乳房重建[J]. 中国微创外科杂志，2008, 8(6): 484-487.
[9]
范志民，宋东，王蕾，等. 保留乳头乳晕的乳腺癌改良根治术和即时乳房假体重建[J]. 中华医学杂志，2007, 87(2): 93-95.
[10]
范林军，姜军. 全腔镜乳腺癌改良根治手术技术[J/CD]. 中华乳腺病杂志(电子版), 2010, 4(1): 17-26.
[11]
Gradishar WJ, Anderson BO, Blair SL, et al. Breast cancer version 3.2014[J]. J Natl Compr Canc Netw，2014, 12(4): 542-590.
[12]
王嘉伟，张树平．乳腺癌保乳术后调强放疗与常规放疗的剂量学比较[J]. 肿瘤研究与临床，2010, 22(3): 182-185.
[13]
邓垒，惠周光，王淑莲，等. 早期乳腺癌保乳术后大分割三维放疗Ⅱ期临床观察[J]. 中华放射肿瘤学杂志，2013, 22(1): 1-4.
[14]
Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [J]. Int J Radiat Oncol Biol Phys，1995, 31(5): 1341-1346.
[15]
Baker J. Augmentation mammaplasty[C]// Owsley JW Jr, ed. Symposium of aesthetic surgery of the breast: Proceedings of the symposium of the educational foundation of the American Society of Plastic and Reconstructive Surgeons and the American Society for Aesthetic Plastic Surgery; Scottsdale, Ariz., November 23-26, 1975. St. Louis: Mosby, 1978: 256-263.
[16]
Fisher B. Breast cancer[J]. Postgrad Med, 1969, 45(4): 73-78.
[17]
De La Cruz L, Moody AM, Tappy EE, et al. Overall survival, disease-Free survival, local recurrence, and nipple-areolar recurrence in the setting of nipple-sparing mastectomy: a meta-analysis and systematic review[J]. Ann Surg Oncol，2015, 22(10): 3241-3249.
[18]
Yang B, Li L, Yan W, et al. The type of breast reconstruction may not influence patient satisfaction in the Chinese population: a single institutional experience[J]. PLoS One，2015, 10(11): e0142900.
[19]
中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2019年版)[J]. 中国癌症杂志，2019, 29(8): 609-679.
[20]
杨昭志，郭小毛. 放射治疗对乳腺癌术后乳房重建的影响[J]. 中国癌症杂志，2008, 18(7): 552-555.
[21]
吴炅，狄根红，陈天文，等. 乳腺癌保留皮肤全乳切除一期乳房重建129例临床分析[J]. 中华外科杂志，2008, 46(10): 737-740.
[22]
Wright JL, Cordeiro PG, Ben-Porat L, et al. Mastectomy with immediate expander-implant reconstruction, adjuvant chemotherapy, and radiation for stage Ⅱ-Ⅲ breast cancer: treatment intervals and clinical outcomes[J]. Int J Radiat Oncol Biol Phys，2008, 70(1): 43-50.
[23]
陈昱明，刘惠珠. 乳腺癌术后放射治疗所致放射性肺炎相关因素分析[J]. 中国肿瘤临床与康复，2008, 15(3): 235-237.
[24]
Marques M, Brown SA, Oliveira I, et al. Long-term follow-up of breast capsule contracture rates in cosmetic and reconstructive cases[J]. Plast Reconstr Surg，2010, 126(3): 769-778.
[25]
Reefy S, Patani N, Anderson A, et al. Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction：a prospective observational study[J]. BMC Cancer，2010, 10: 171.
[26]
Massabeau C, Fournier-Bidoz N, Wakil G, et al. Implant breast reconstruction followed by radiotherapy: can helical tomotherapy become a standard irradiation treatment ？[J]. Med Dosim，2012, 37(4): 425-431.
[27]
郑瑛，陈钦，贾苗苗，等. 保乳术后放射治疗对乳腺癌局部淋巴结转移患者预后的影响[J]. 中国肿瘤临床，2014, 41(21): 1394-1398.
[28]
王文彦，张柏林，徐晓洲，等. 新辅助化疗后腋窝淋巴结分期和病理缓解状态对乳腺癌患者预后的影响[J]. 中华肿瘤杂志，2015, 37(3): 195-199.
[29]
Mukesh MB, Duke S, Parashar D, et al. The Cambridge post-mastectomy radiotherapy (C-PMRT) index: a practical tool for patient selection[J]. Radiother Oncol，2014, 110(3): 461-466.
[1] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[2] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[3] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[4] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[5] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[6] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[7] 朱文婷, 顾鹏, 孙星. 非酒精性脂肪性肝病对乳腺癌发生发展及治疗的影响[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 371-375.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 刘世君, 马杰, 师鲁静. 胃癌完整系膜切除术+标准D2根治术治疗进展期胃癌的近中期随访研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 27-30.
[10] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[11] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[12] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[13] 王露, 周丽君. 全腹腔镜下远端胃大部切除不同吻合方式对胃癌患者胃功能恢复、并发症发生率的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 92-95.
[14] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[15] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号